Advanced Therapies Week 2026

Advanced Therapies Week 2026, an event organized by Phacilitate, will take place from February 9 to 12 at the San Diego Convention Center (USA).

This congress aims to share scientific innovation, establish strategic partnerships, and drive the acceleration of precision medicine through networking, conferences, and the exhibition of cutting-edge medical technology.

In its 21st year, Advanced Therapies Week is the leading biotechnology collaboration event in the United States, bringing together leaders in research, therapeutic development, and advanced manufacturing.

The list of over 530 attending companies is available here.

Building translational infrastructure for emerging biotech

This fireside chat describes approaches to aligning discovery outcomes with clinical needs, establishing appropriate workflows, and building systems that enhance translational fidelity and predictive validity.

10/02/2026

11:00 am – 11:30 am

Moderator:

• Robert Fabregat, CEO. Biocat

Speakers:

• Ajinkya Sase, Senior Applications Scientist. Vector Biolabs
• Zoya Gluzman-Poltorak, Co-founder and CEO. Forta Bio

What does a ‘Trial Ready’ Therapeutic look like in 2026?

This discussion highlights the benchmarks, frameworks, and decision criteria that support readiness, optimize development, and mitigate early clinical risk.

10/02/2026

3:00 pm – 3:45 pm

Moderator:

• Anthony Ting, Chief Scientific Officer. Kiji Therapeutics

Speakers:

• Jamie Pierson, Head of Cell and Gene Therapy. Parexel
• Montse Daban, Director of Strategic Analysis and International Relations. Biocat

Clinical data thresholds, funding strategies, and risk management

This featured session focuses on how organizations can design funding strategies aligned with scientific milestones, reduce development risk, and position therapies for successful launch and scalability.

11/02/2026

2:30 pm – 3:00 pm

Speakers:

• Madan Jagasia, Chief Executive Officer. Obsidian Therapeutics
• Montse Daban, Director of Strategic Analysis and International Relations. Biocat

Global CGT clinical development: funding, trials, and approvals

This discussion explores methods to secure resources, design efficient trials, and meet approval requirements while preserving predictive validity and program readiness.

11/02/2026

4:15 pm – 4:45 pm

Speaker:

• Miguel Forte, Chief Executive Officer and ISCT President. Kiji Therapeutics

20% discount for companies and organizations in the BioRegion of Catalonia that use the code BIOCAT20 at the time of registration